BIO-EC Program Description

We are launching a funding program to support up to 40 projects around the world that will swiftly initiate research in areas that can underpin bio electronics medicines.
We will be interested in projects that begin detailing how nerves in the body are related to particular diseases, understand the firing patterns of those nerves, and explore new technologies that will enable us to interface with multiple individual nerve fibers.
We have also created a new fund that invests in companies that pioneer bioelectronic medicines and technologies.
The fund will focus investments in three areas: new start-up companies that aim to pursue the vision of bioelectronic medicines; existing companies with technologies that are interacting with the peripheral nervous system through first-generation devices that can stimulate or block electrical impulses; and companies advancing technology platforms that will underpin these treatment methods.
This program will be integrated by a small in-house research team. The team will also crowd-source ideas from the global scientific community to identify which specific disease with a major peripheral neural control component would be the best proof of principle for bioeletronic medicines.
We are launching a funding program to support up to 40 projects around the world that will swiftly initiate research in areas that can underpin bio electronics medicines.
This program will be integrated by a small in-house research team. The team will also crowd-source ideas from the global scientific community to identify which specific disease with a major peripheral neural control component would be the best proof of principle for bioeletronic medicines.
We launched a Innovation Challenge Fund (ICF) in December 2014 in order to fund teams who wish to participate. To encourage open innovation in the field of bioelectronic medicine, any tools and technologies that come from the ICF funded work and the Innovation Challenge’s winning entry will be made freely available to the global research community.
The intention is that this will foster an environment of collaboration between researchers from different institutions, which in turn will accelerate the development of this new generation of medicines.
We convened an international conference for the bioelectronic research community in April 2015, encouraging researchers to meet, build relationships and share early findings, and define the largest single challenge currently facing our efforts to develop bioelectronic medicines.
We believe that bioelectronic medicine will open up a whole new front in our mission to control and reverse disease. Our goal is to have the first medicine that speaks the electrical language of our body ready for approval by the end of this decade.